Written and maintained by CASRAI Editorial Board
Last updated
Restriction fragment length polymorphism (RFLP) is a molecular biology technique that detects sequence variations in homologous DNA by analyzing fragment lengths after restriction endonuclease digestion. Point mutations, insertions, or deletions alter cleavage sites, producing distinct electrophoretic band patterns used for genotyping, allele tracking, and microbial strain identification.
Short Answer: What Is Restriction Fragment Length Polymorphism?
Restriction fragment length polymorphism (RFLP) is a variation in homologous DNA sequences detected through fragments of differing lengths following restriction enzyme digestion. When DNA is treated with a sequence-specific restriction endonuclease, mutations within recognition sites alter cleavage patterns. The resulting fragments are resolved by gel electrophoresis, providing a reproducible, codominant molecular marker for genetic analysis.
Definition and Scope: Molecular Basis of RFLP
In molecular genetics, restriction fragment length polymorphism refers both to sequence variation at restriction sites and to the laboratory assay used to detect it. As defined by the National Human Genome Research Institute (NHGRI), RFLP reflects base-pair differences that create, abolish, or shift recognition sequences targeted by restriction endonucleases. Because homologous chromosomes can differ at these sites, heterozygous samples display both maternal and paternal fragment sizes, making RFLP an inherently codominant marker system.
Most RFLPs arise from single nucleotide polymorphisms (SNPs) that eliminate or create an endonuclease recognition sequence. They can also reflect variable numbers of tandem repeats (VNTRs) or indels positioned between flanking cleavage sites. The vast majority of genomic RFLPs reside within non-coding introns or intergenic spacers, functioning as neutral genetic landmarks across chromosomal linkage maps.
How It Works: Workflows and Protocols in Practice
The RFLP technique analyzes sequence variation through two distinct laboratory workflows: traditional Southern blot RFLP and amplicon-based PCR-RFLP.
Traditional Southern Blot RFLP Workflow
As documented in Current Protocols in Human Genetics (PMID: 18428271), classical Southern-based RFLP follows a multi-day procedure:
- Genomic DNA Extraction: Isolates 5 to 10 micrograms of intact, high-molecular-weight genomic DNA per sample to ensure adequate hybridization signal.
- Restriction Endonuclease Digestion: Digested with an excess of a specific Type II restriction enzyme (such as EcoRI, HindIII, or HaeIII) to ensure complete cleavage.
- Agarose Gel Electrophoresis: Fragments separate by size on a 0.8% to 1.2% agarose gel. When analyzing digests, labs evaluate whether anomalous band migration represents true polymorphism or artifactual PCR product smear and gel degradation.
- Gel Pretreatment and Transfer: The gel undergoes depurination (0.25 N HCl) and alkaline denaturation (0.5 M NaOH, 1.5 M NaCl), transferring single-stranded fragments via capillary action onto a nylon membrane using standard saline-sodium citrate (SSC) buffer over 12 to 18 hours.
- Hybridization and Detection: The membrane is UV crosslinked, hybridized with a labeled single-copy probe, washed under high stringency, and visualized by autoradiography or chemiluminescence as detailed in the Southern blot protocol guide.
Modern PCR-RFLP (Cleaved Amplified Polymorphic Sequences)
To eliminate blotting and microgram DNA requirements, modern workflows employ PCR-RFLP (also known as Cleaved Amplified Polymorphic Sequences, or CAPS). Sequence-specific primers first amplify a 200 to 1,000 base-pair target region following standard PCR for genotyping protocols. The resulting amplicon is digested directly with a restriction endonuclease, and fragments are resolved on high-percentage agarose (2% to 3.5%) or polyacrylamide gels with fluorescent nucleic acid stains, delivering results in 3 to 5 hours.
Types and Related Concepts: Sourced Marker Comparison
The table below summarizes foundational molecular marker platforms across standardized technical parameters documented by NHGRI, NCBI, and New England Biolabs:
| Analytical Platform | Template Input | Turnaround Time | Resolution & Dominance | Detection Method |
|---|---|---|---|---|
| Southern Blot RFLP | 5–10 µg intact HMW genomic DNA | 3–5 days | Codominant (biallelic or multi-allele VNTR) | Labeled probe hybridization; autoradiography |
| PCR-RFLP (CAPS) | 10–50 ng genomic DNA | 3–5 hours | Codominant (cleavage site presence/absence) | Gel electrophoresis; fluorescent intercalating dye |
| AFLP | 100–500 ng genomic DNA | 1–2 days | Dominant (band presence/absence) | Denaturing PAGE or capillary electrophoresis |
| STR Profiling | 0.5–2 ng intact or degraded DNA | 2–4 hours | Codominant (discrete digital repeat numbers) | Automated multicolor capillary electrophoresis |
Where It Matters for Labs, Clinics, and Method Selection Decisions
Although large-scale genomic mapping has shifted to microarrays and NGS, PCR-RFLP remains valuable in specific laboratory settings:
- Single-Locus Mutation Screening: In academic research, PCR-RFLP offers rapid, cost-effective verification of targeted point mutations or gene knockouts (such as CRISPR-Cas9 edits that alter a restriction site) without fluorescent probe synthesis or sequencing costs.
- Microbial and Fungal Species Typing: PCR-RFLP of conserved ribosomal genes (such as 16S rRNA or hsp65 in mycobacteria) provides reliable species differentiation using basic thermal cyclers and standard gel documentation systems.
- Resource-Constrained and Educational Facilities: Where capillary sequencers are unavailable, amplicon restriction digestion demonstrates Mendelian codominance and allelic segregation with minimal equipment overhead.
Common Laboratory Misunderstandings
- Misunderstanding 1: Assuming RFLP always indicates pathology. An RFLP simply indicates sequence variation. While certain polymorphisms track with genetic conditions (such as the loss of a DdeI site in the sickle cell beta-globin gene), most RFLPs occur in non-coding regions and serve as neutral genetic markers.
- Misunderstanding 2: Equating Southern RFLP with PCR-RFLP. Traditional RFLP requires microgram quantities of high-molecular-weight DNA, membrane transfer, and labeled probes. PCR-RFLP couples targeted primer amplification with restriction digestion, using nanogram-scale template and direct gel visualization.
- Misunderstanding 3: Confusing incomplete digestion with heterozygosity. In PCR-RFLP, partial enzymatic restriction caused by expired buffer, insufficient incubation, or excess template produces cut and uncut bands that mimic a heterozygous genotype. Runs must include homozygous cut and uncut reference controls.
- Misunderstanding 4: Expecting Type IV enzymes to cut at fixed palindromes. Unlike Type II enzymes used in RFLP, Type IV enzymes target modified/methylated bases and cleave variable distances between recognition sites, making them unsuitable for classic sequence-length profiling.
Frequently Asked Questions
What is the restriction fragment length polymorphism (RFLP) technique?
The RFLP technique is an analytical method that identifies DNA sequence variations by digesting homologous DNA molecules with sequence-specific restriction enzymes and separating the resulting fragments by size. Variations in recognition sites alter cleavage locations, creating distinct, individual-specific fragment length patterns detected by gel electrophoresis or Southern blotting.
Why are RFLPs not used anymore?
Southern-based RFLPs have been replaced in high-throughput and forensic laboratories because they require large quantities of intact genomic DNA (5–10 µg), rely on multi-day protocols, historically utilized hazardous radioactive probes, and lack the high multiplexing capability and digital allele standardization of modern STR profiling and next-generation sequencing. In pathogen surveillance, public health networks such as CDC PulseNet transitioned from macro-restriction methods like PFGE electrophoresis to whole-genome sequencing.
What are the four types of genetic markers?
The four primary types of genetic markers are:
- Morphological Markers: Observable physical traits (pigmentation, height, seed shape) requiring no laboratory equipment but vulnerable to environmental influence.
- Biochemical Markers: Isozymes and allozymes that resolve protein charge and mobility variations on non-denaturing gels.
- Cytological Markers: Microscopic chromosomal features (karyotype bands, translocations, inversions) scored in dividing cells.
- Molecular Markers: Direct nucleotide sequence variations (RFLPs, AFLPs, microsatellites/STRs, and SNPs) that are stable, abundant, and developmental-stage independent.
What are type 4 restriction enzymes?
Type 4 (Type IV) restriction enzymes are modification-dependent endonucleases that recognize and cleave DNA containing methylated, hydroxymethylated, or glucosyl-hydroxymethylated bases (such as 5-methylcytosine or N6-methyladenine). Documented by New England Biolabs (NEB), prototypical examples include E. coli McrBC and Mrr. Unlike the Type II enzymes used in RFLP, Type IV systems do not cleave at unmodified, fixed palindromic sequences; instead, they function in bacterial host defense against modified bacteriophages.
Sources
- National Human Genome Research Institute (NHGRI). “Restriction Fragment Length Polymorphism (RFLP).” Talking Glossary of Genomic and Genetic Terms. URL: https://www.genome.gov/genetics-glossary/Restriction-Fragment-Length-Polymorphism. Checked 2026-11-07.
- Current Protocols in Human Genetics. “Restriction fragment length polymorphism analysis.” Unit 2.4, PMID: 18428271, DOI: 10.1002/0471142905.hg0204s04. Checked 2026-11-07.
- New England Biolabs (NEB). “Types of Restriction Endonucleases and Cleavage Properties” and “McrBC / Modification-Dependent Endonucleases.” URL: https://www.neb.com/en-us/tools-and-resources/selection-guides/alphabetized-list-of-recognition-specificities. Checked 2026-11-07.
- Centers for Disease Control and Prevention (CDC). “PulseNet: Molecular Subtyping and Foodborne Pathogen Surveillance.” URL: https://www.cdc.gov/pulsenet/pathogens/index.html. Checked 2026-11-07.







